Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123157) titled 'CreNeuroSTM CNS Fish Oil Plus Softgels A randomized, double-blind, double-dummy, parallel-controlled, multi-center clinical study on the efficacy and safety of improving mild to moderate depression with positive drugs' on April 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Southwest Medical University Affiliated Hospital

Condition: Depression

Intervention: Experimental Group:Take 6 capsules of CreNeuroSTM CNS Fish Oil Plus Softgels daily (approximately 790mg per capsule), divided into 2 doses. Also take 1 capsule of fluoxetine hydrochloride placebo. Continue for 8 weeks. During...